"What Are the Latest Trends in Lung Cancer Research?"... Korean Society of Lung Cancer to Hold International Conference Until Next Month 1

The Korean Association for Lung Cancer will hold the Korean Association for Lung Cancer International Conference (KALC IC 2023) for two days from the 30th to the 1st of next month at Lotte Hotel World in Seoul. The KALC International Conference is a gathering of domestic and international medical professionals and scientists involved in all fields related to lung cancer to discuss the latest topics.

The Korean Association for Lung Cancer will hold the Korean Association for Lung Cancer International Conference (KALC IC 2023) for two days from the 30th to the 1st of next month at Lotte Hotel World in Seoul.
[Photo by Byeon Seon-jin]

This international conference has attracted over 700 researchers from 25 countries worldwide. After reviewing 161 research results submitted from 12 countries over two days, 22 abstracts will be presented. Additionally, prominent domestic experts and 32 overseas scholars will participate in lectures and discussions, making it a platform for international academic exchange.

On the first day of the conference, Professor Justin Gainor from Massachusetts General Hospital (MGH), USA, will present on biomarkers of resistance to immune checkpoint inhibitors. On the last day, Professor Martin Reck from Germany will lecture on the latest clinical data and future development prospects of immune checkpoint inhibitors. This is expected to provide a broad understanding of the biological mechanisms and clinical effects of immune checkpoint inhibitors, which have become key drugs in lung cancer treatment.

Other topics to be discussed include advanced diagnostic techniques such as early diagnosis of lung cancer, staging, and molecular pathology, as well as the latest trends in surgery, radiation, and chemotherapy. Representative topics include trends in pre- and post-surgical immune checkpoint therapy, applications of various omics techniques in lung cancer, and new lung cancer classification methods.

The conference also plans joint symposiums with various international societies. The Korean Association for Lung Cancer will hold a special session with the World Lung Cancer Federation to share research status and future plans of both societies, aiming to establish a close cooperative relationship. With the Japanese Lung Cancer Society, multidisciplinary discussions will be held among Korean and Japanese lung cancer medical professionals on the best treatment methods for rare metastatic lung cancer requiring multidisciplinary approaches. Furthermore, through a joint symposium with the Health Insurance Review & Assessment Service, issues related to domestic new drug approvals and insurance coverage will be discussed, and with the Korean Oncology Nursing Society, discussions will focus on understanding the entire treatment journey of lung cancer patients and ways to alleviate their suffering.

Myung-Joo Ahn, Chairperson of the Korean Association for Lung Cancer, said, “We expect that members from departments such as internal medicine, thoracic surgery, radiation oncology, pathology, and radiology, who are working on the front lines of multidisciplinary lung cancer treatment, along with researchers specializing in preventive medicine and basic medical sciences, will share the latest knowledge to elevate the level of lung cancer treatment.” She added, “We hope this conference will be an academic event where the achievements of Korean lung cancer researchers can contribute to the advancement of lung cancer research internationally, beyond Korea.”

This content was produced with the assistance of AI translation services.